#cardiovascular disease

An early clinical trial suggests a single infusion of VERVE-102 can sharply lower LDL cholesterol, pointing to a possible alternative to lifelong medication.

Researchers on the International Space Station are using stem-cell-derived heart tissues and the harsher behavior of bacteria in space to study how pneumonia infections can lead to long-term cardiovascular damage.

A multinational validation study spanning 6.4 million people is putting two of the world’s most important cardiovascular risk tools under unusually large-scale review, with implications for prevention strategy and clinic

Researchers analyzing data from 157 Chinese cities found that exposure to extreme heat, cold, and precipitation is associated with higher cardiovascular disease risk among middle-aged and older adults.

A prespecified analysis of the SELECT trial found semaglutide reduced major adverse cardiovascular events in patients at elevated risk of substantial liver fibrosis while also lowering fatty liver index versus placebo.